NCT03754335

Brief Summary

Headache control is one of the major challenges in patients who suffered an acute aneurysmal subarachnoid hemorrhage (aSAH). Headache affects 90% of the patient and is resistant to the major pain medication. It results from the increased intracranial pressure and the inflammation caused by the accumulation of arterial blood in the subarachnoid space. Hemorrhagic cerebrospinal fluid (CSF) removal by a lumbar puncture (LP), is well tolerated, reduces intracranial pressure and accelerates the clearance of the blood products from CSF. Nonetheless it has never been tested in a randomized trial. The investigators aim to compare in patients who experienced a low grade aSAH, the variation of headache intensity after CSF removal by LP vs. Sham LP in addition to predefined analgesic protocol management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 27, 2018

Completed
1 day until next milestone

Study Start

First participant enrolled

November 28, 2018

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

May 29, 2026

Status Verified

May 1, 2026

Enrollment Period

4 years

First QC Date

November 19, 2018

Last Update Submit

May 28, 2026

Conditions

Keywords

Aneurysmal subarachnoid hemorrhagelumbar punctureheadache

Outcome Measures

Primary Outcomes (1)

  • Difference of headache mean intensity variation measured after a lumbar puncture or a sham LP.

    The mean intensity will be assessed using the verbal rating scales (VRS). It is a scale administered by the medical team, which brings together the score given by the patient between 0 and 10 (0 = absence of pain; 10 = maximum of conceivable pain)Headache mean intensity variation will be calculated by the difference between these scores evaluated 24 hours before and the 24 hours after the procedure.

    24 hours after the inclusion

Secondary Outcomes (7)

  • Difference of variation in the mean intensity of headache

    48 hours

  • Difference of maximal headache intensity

    48 hours

  • Kinetic of headache intensity

    7 days

  • Difference of responding patients

    7 days

  • Occurrence of a clinical deterioration

    1 day

  • +2 more secondary outcomes

Study Arms (2)

Lumbar puncture

EXPERIMENTAL

Lumbar puncture in addition to a predefined analgesic protocol Patients will be randomized between the 3rd and 5th days following aneurismal rupture.

Procedure: Lumbar puncture

Sham lumbar puncture

ACTIVE COMPARATOR

Sham lumbar puncture in addition to a predefined analgesic protocol Patients will be randomized between the 3rd and 5th days following aneurismal rupture.

Procedure: Lumbar puncture

Interventions

Patient will be managed according to the current international recommendations in the Toulouse acute stroke center. In the absence of clear recommendation in the literature headache will be treated according to our local predefined analgesic protocol: paracetamol 1g/6 h, and if the numerical scale ≥ 4 : continuous intravenous morphine starting at 1mg/h and increased per 0.5 mg/h every hour if numerical scale remains ≥ 4. Lumbar puncture will be performed between day 3 and day 5 after subarachnoid hemorrhage onset by an independent scientist from our clinical investigator center. 30-mL CSF will be removed by LP. Sham LP consisting in superficial skin puncture by a subcutaneous needle (27 gauge needle) during the usual procedure will be performed at the same time point.

Also known as: Sham Lumbar Puncture
Lumbar punctureSham lumbar puncture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years
  • Low grade subarachnoid hemorrhage (WFNS score between 1 and 3)
  • Aneurysmal rupture ≤ 5 days
  • Ruptured aneurysm secured by coiling since at least 48 h
  • Headache with a mean numeric verbal scale ≥ 4/10 during the last 24 hours
  • No contraindication for lumbar puncture
  • Affiliation to french social security
  • Person able to express her consent and to assess own headache intensity

You may not qualify if:

  • Minor,
  • Pregnancy, breastfeeding
  • Subarachnoid hemorrhage without aneurysm
  • Ruptured aneurysm not secured
  • High grade (WFNS 4 and 5) subarachnoid hemorrhage
  • Efficient anticoagulation
  • External ventricular drain placed before randomisation
  • People under legal protection
  • Participation to another research study with an ongoing disqualification period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Toulouse

Toulouse, 31059, France

Location

MeSH Terms

Conditions

Subarachnoid HemorrhageHeadache

Interventions

Spinal Puncture

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

BiopsySpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, NeurologicalPuncturesTherapeuticsSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Lionel Calvière, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
This procedure is to be able to easily randomize half of the patients into a "sham" LP arm passed by independent practitioners of the investigators in charge of the patient, which allows a good double-blind study.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized, double blind, prospective monocentric trial evaluating in parallel groups
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2018

First Posted

November 27, 2018

Study Start

November 28, 2018

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

May 29, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations